ArticleMed (New York, N.Y.)2024

Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.

Anne Knisely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.